Search research articles
Contact Us
Filters
Showing results (101-110 of 161) with videos related to
Page
of 17
Sort By:
Transplantation and Cellular Therapy
|
December 27, 2023
Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience
Danai Dima, James A Davis, Nausheen Ahmed, et al.
Blood Cancer Journal
|
May 31, 2024
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy
Danai Dima, Al-Ola Abdallah, James A Davis, et al.
Blood Cancer Journal
|
July 30, 2024
Non-canonical FLT3 alterations reveal novel germline FLT3 variants leading to somatic gene rescue mutations
Jaymeson Gordon, Carlos Bravo-Perez, Luca Guarnera, et al.
Schizophrenia Bulletin
|
April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome
Gemma Modinos, Paul Allen, Andre Zugman, et al.
Head & Neck
|
June 5, 2023
Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement
Nerea Lopetegui-Lia, Danai Dima, David Scott Buchberger, et al.
Transplantation and Cellular Therapy
|
June 13, 2024
Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma
William Wesson, Danai Dima, Nahid Suleman, et al.
Hematological Oncology
|
June 14, 2024
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy
Danai Dima, Utkarsh Goel, Aishwarya Sannareddy, et al.
Transplantation and Cellular Therapy
|
June 10, 2026
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapies
Agrima Mian, Rafaella Litvin, Danai Dima, et al.
Blood Neoplasia
|
April 20, 2026
Safety of MMR vaccination for patients with myeloma receiving daratumumab after autologous stem cell transplantation
James A Davis, Jessica McElwee, Rebecca Gonzalez, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 27, 2025
Real-World Practice in the Management of Transplant-Eligible Newly Diagnosed Multiple Myeloma: A US-Based Cross-Sectional National Survey
Hossam M Ali, Zainab Yusufali Motiwala, Yara Shatnawi, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 161) with videos related to
Sort By:
Page
of 17
Transplantation and Cellular Therapy
|
December 27, 2023
Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience
Danai Dima, James A Davis, Nausheen Ahmed, et al.
Blood Cancer Journal
|
May 31, 2024
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy
Danai Dima, Al-Ola Abdallah, James A Davis, et al.
Blood Cancer Journal
|
July 30, 2024
Non-canonical FLT3 alterations reveal novel germline FLT3 variants leading to somatic gene rescue mutations
Jaymeson Gordon, Carlos Bravo-Perez, Luca Guarnera, et al.
Schizophrenia Bulletin
|
April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome
Gemma Modinos, Paul Allen, Andre Zugman, et al.
Head & Neck
|
June 5, 2023
Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement
Nerea Lopetegui-Lia, Danai Dima, David Scott Buchberger, et al.
Transplantation and Cellular Therapy
|
June 13, 2024
Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma
William Wesson, Danai Dima, Nahid Suleman, et al.
Hematological Oncology
|
June 14, 2024
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy
Danai Dima, Utkarsh Goel, Aishwarya Sannareddy, et al.
Transplantation and Cellular Therapy
|
June 10, 2026
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapies
Agrima Mian, Rafaella Litvin, Danai Dima, et al.
Blood Neoplasia
|
April 20, 2026
Safety of MMR vaccination for patients with myeloma receiving daratumumab after autologous stem cell transplantation
James A Davis, Jessica McElwee, Rebecca Gonzalez, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 27, 2025
Real-World Practice in the Management of Transplant-Eligible Newly Diagnosed Multiple Myeloma: A US-Based Cross-Sectional National Survey
Hossam M Ali, Zainab Yusufali Motiwala, Yara Shatnawi, et al.
Page
of 17